Profession Pharmacist
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Protect Yourself from Liability: ISMP's New Targeted Medication Safety Best Practices for Community Pharmacy - Part 2
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: HPSOWEB022224Published: 2024Expires: 4/3/2027DetailsRequired Passing Score: 1/1 (100%)Collections: Pharmacist -- Focus on Malpractice PreventionMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Protect Yourself from Liability: ISMP's New Targeted Medication Safety Best Practices for Community Pharmacy
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: HPSOWEB022224Published: 2024Expires: 2/22/2027DetailsRequired Passing Score: 1/1 (100%)Collections: Pharmacist -- Focus on Malpractice PreventionMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Safety Consideration for Minimizing Vaccination-Related Errors
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: HPSOWEB0224Published: February 2024Expires: 12/14/2025DetailsRequired Passing Score: 1/1 (100%)Collections: Pharmacist -- Focus on Malpractice PreventionMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} USP <795> Final Version: Overview of the updated requirements
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: CCSWEB0322233HPublished: April 2023Expires: 4/30/2025DetailsRequired Passing Score: 1/1 (100%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Prescription Opioid Abuse and Addiction: How Can We Curb the Trends? - Vol. 33, No. 5
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM1217PHPublished: April 2019Expires: 9/13/2025DetailsRequired Passing Score: 8/10 (80%)Topics: Opioids -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Chronic Pain, Impulsivity, and Risk for Opioid Misuse
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM0718PHPublished: AprilExpires: 9/13/2025Sources: Allied Health CollectionDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Improving Adherence in Pediatric Chronic Pain: An Introduction to Motivational Interviewing - Vol. 33, No. 10
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: TPM0518PHPublished: April 2019Expires: 9/13/2025DetailsRequired Passing Score: 8/10 (80%)Categories: Pain ManagementSpecialties: PediatricsTopics: Pain , Pain Management -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Lenvatinib vs. Sorafenib as First-Line Treatment for Unresectable HCC
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1218PPublished: April 2019Expires: 9/13/2025Sources: Allied Health CollectionDetailsRequired Passing Score: 8/10 (80%)Categories: Pharmacology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Talazoparib in Advanced Breast Cancer With a Germline BRCA Mutation
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0219PHPublished: April 2019Expires: 9/13/2025Sources: Allied Health CollectionDetailsRequired Passing Score: 8/10 (80%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Treating PID as Its Drug Resistance Surges
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: EMN1017PHPublished: April 2019Expires: 9/13/2025Sources: Allied Health CollectionDetailsRequired Passing Score: 7/10 (70%)